Clinical Trial Update: Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating EEG-based prediction for antidepressant response to sertraline and escitalopram has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Sertraline (Sertraline)

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN